Categories


Jury hits testosterone therapy maker AbbVie with $150 million in punitive damages

July 24, 2017 - The jury found that AbbVie fraudulently marketed AndroGel by creating a condition dubbed “Low T,” presenting the product directly to men as a kind of fountain of youth. Read More


MDL established for Physiomesh plaintiffs

July 20, 2017 - The U.S. Judicial Panel on Multidistrict Litigation created a multidistrict litigation (MDL) for claims against Physiomesh makers Ethicon and Johnson & Johnson. Read More


Risperdal legal troubles continue to mount

July 13, 2017 - The suit was filed by a number of child advocacy organizations on behalf of children in the Missouri foster care system who were “inappropriately provid[ed] psychotropic drugs” with... Read More


High-viscosity bone cement may sacrifice surgical benefits

June 1, 2017 - A person usually opts for a total knee replacement (TKR) to regain their quality of life. Read More


Chemotherapy drug Taxotere lawsuits skyrocketing over permanent hair loss

April 27, 2017 - Many cancer patients who took the chemotherapy drug Taxotere are now experiencing permanent hair loss. Read More


Dexilant use linked to serious, repeated episodes of vertigo

April 20, 2017 - Dexilant and Dexilant Solutab are prescription drugs in a class of drugs known as proton pump inhibitors (PPIs). Read More


Zimmer Biomet shoulder replacement system recalled due to excessive fracturing

April 6, 2017 - Zimmer issued the Class 1 Recall only after patients suffered from fractures in the humeral tray component. Read More


Bristol-Myers Squibb top-selling antipsychotic Abilify linked to users’ compulsive gambling

March 8, 2017 - When the FDA reviewed Abilify’s adverse events reports, 184 of them linked the drug with the impulse-control problems that developed in adults and children taking Abilify. The most... Read More


FDA orders black box warning placed on power morcellators used in hysterectomy, myomectomy procedure

November 25, 2014 - The Food and Drug Administration (FDA) is warning that laparoscopic power morcellators not be used to remove uteruses (hysterectomies) or fibroids (myomectomies) in the vast majority of... Read More


Actos verdict illustrates companies that co-promote drugs can be held liable for injuries, failure to warn

September 4, 2014 - A federal judge’s decision not to overturn a jury’s $9 billion verdict against Takeda Pharmaceutical Co. and Eli Lilly for withholding bladder cancer risks from doctors and patients... Read More


back to top